Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Georgi Iskrov, Georgi Vasilev & Rumen Stefanov. (2019) What could gene therapies learn from orphan drugs’ post-regulatory approval access in the EU?. Expert Opinion on Orphan Drugs 7:9, pages 407-414.
Read now
Read now
P Lasalvia, L Prieto-Pinto, M Moreno, J Castrillón, G Romano, N Garzón-Orjuela & D Rosselli. (2019) International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research 19:4, pages 409-420.
Read now
Read now
Maria Kamusheva, Konstantin Tachkov, Guenka Petrova, Alexandra Savova & Manoela Manova. (2018) Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles. Expert Opinion on Orphan Drugs 6:2, pages 95-104.
Read now
Read now